Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
The Six Months Ended of Financial Results Briefing for the FYE March 2026
Consolidated Financial Results for the Six Months Ended September 30, 2025
Notice Regarding Revision of Consolidated Earnings Forecasts for the Full Year of the FYE March 31 2026
Japan Medical Dynamic Marketing, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 39%
Notice Regarding Revision of Consolidated Earnings Forecasts for the 2Q, and Revision of Consolidated Full Year of the FYE March, 2026
Japan Medical Dynamic Marketing, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 40% Decrease
Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP]
Japan Medical Dynamic Marketing, Apr-Jun (1Q) Ordinary Profit Decreases by 71%
Matters Concerning Controlling Shareholders, etc
Financial Results Briefing for the Fiscal Year Ending March 2025
Notice Regarding Differences between Full-Year Consolidated Financial Forecasts and Actual Results for the Fiscal Year Ended March 2025
Summary of Consolidated Financial Results for the Fiscal Year Ended March 2025 Japanese GAAP】
Japan Medical Dynamic Marketing, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Japan Medical Dynamic Marketing, The Current Fiscal Year Net Income Revised Downward to a Loss
Summary of Consolidated Financial Results for the Nine Months Ended of the Fiscal Year Ending March 2025 [Japanese GAAP]
Japan Medical Dynamic Marketing, Oct-Dec (3Q) Ordinary Profit Decreases by 11%
〔Delayed〕The Six Months Ended of Financial Results Briefing for the Fiscal Year Ending March 2025
Japan Medical Dynamic Marketing, INC., July-September (2Q) Ordinary Profit Increases by 1%
Summary of Consolidated Financial Results for the Six Months Ended of the Fiscal Year Ending March 2025 [Japanese GAAP]